APO Research
Talk to an analyst

APO RESEARCH · REPORT

Scopolamine

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

Selected research

Market Outlook & Growth Opportunities

Global Scopolamine Market Outlook and Growth Opportunities 2026

1 January 2026194 pages

Choose your research edition.

Industry ResearchScopolamine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Scopolamine Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Scopolamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Scopolamine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Scopolamine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.

The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.

This report provides an overview of the global Scopolamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Scopolamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Scopolamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Scopolamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Scopolamine Segment by Company

Alkaloids of Australia

Boehringer Ingelheim

Fine Chemicals Corporation

Phytex Australia

Alchem International

Guangzhou Hanfang

Alkaloids Corporation

Luyin

Scopolamine Segment by Type

Scopolamine Butylbromide

Scopolamine Hydrobromide

Others

Scopolamine Segment by Application

Tablets

Injection

Patches

Scopolamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Scopolamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Scopolamine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Scopolamine significant trends, drivers, influence factors in global and regions.

6. To analyze Scopolamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Scopolamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Scopolamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Scopolamine industry.

Chapter 3: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Scopolamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Scopolamine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Scopolamine Industry Trends Table 2. Scopolamine Industry Drivers Table 3. Scopolamine Industry Opportunities and Challenges Table 4. Scopolamine Industry Restraints Table 5. Global Scopolamine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Scopolamine Revenue Share by Company (2021-2026) Table 7. Global Scopolamine Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Scopolamine Sales Volume Share by Company (2021-2026) Table 9. Global Scopolamine Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Scopolamine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Scopolamine Key Company Manufacturing Base & Headquarters Table 12. Global Scopolamine Company, Product Type & Application Table 13. Global Scopolamine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Scopolamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Scopolamine Butylbromide Table 18. Significant Companies of Scopolamine Hydrobromide Table 19. Significant Companies of Others Table 20. Global Scopolamine Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 21. Global Scopolamine Sales Volume by Type (2021-2026) & (Kg) Table 22. Global Scopolamine Sales Volume by Type (2027-2032) & (Kg) Table 23. Global Scopolamine Sales Volume Share by Type (2021-2026) Table 24. Global Scopolamine Sales Volume Share by Type (2027-2032) Table 25. Global Scopolamine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Scopolamine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Scopolamine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Scopolamine Sales Value Share by Type (2021-2026) Table 29. Global Scopolamine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Tablets Table 31. Significant Companies of Injection Table 32. Significant Companies of Patches Table 33. Global Scopolamine Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 34. Global Scopolamine Sales Volume by Application (2021-2026) & (Kg) Table 35. Global Scopolamine Sales Volume by Application (2027-2032) & (Kg) Table 36. Global Scopolamine Sales Volume Share by Application (2021-2026) Table 37. Global Scopolamine Sales Volume Share by Application (2027-2032) Table 38. Global Scopolamine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Scopolamine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Scopolamine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Scopolamine Sales Value Share by Application (2021-2026) Table 42. Global Scopolamine Sales Value Share by Application (2027-2032) Table 43. Global Scopolamine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 44. Global Scopolamine Sales by Region (2021-2026) & (Kg) Table 45. Global Scopolamine Sales Market Share by Region (2021-2026) Table 46. Global Scopolamine Sales by Region (2027-2032) & (Kg) Table 47. Global Scopolamine Sales Market Share by Region (2027-2032) Table 48. Global Scopolamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Scopolamine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Scopolamine Sales Value Share by Region (2021-2026) Table 51. Global Scopolamine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Scopolamine Sales Value Share by Region (2027-2032) Table 53. Global Scopolamine Market Average Price (US$/Kg) by Region (2021-2026) Table 54. Global Scopolamine Market Average Price (US$/Kg) by Region (2027-2032) Table 55. Global Scopolamine Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. Global Scopolamine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Scopolamine Sales by Country (2021-2026) & (Kg) Table 58. Global Scopolamine Sales Market Share by Country (2021-2026) Table 59. Global Scopolamine Sales by Country (2027-2032) & (Kg) Table 60. Global Scopolamine Sales Market Share by Country (2027-2032) Table 61. Global Scopolamine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Scopolamine Sales Value Market Share by Country (2021-2026) Table 63. Global Scopolamine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Scopolamine Sales Value Market Share by Country (2027-2032) Table 65. Alkaloids of Australia Company Information Table 66. Alkaloids of Australia Business Overview Table 67. Alkaloids of Australia Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 68. Alkaloids of Australia Scopolamine Product Portfolio Table 69. Alkaloids of Australia Recent Development Table 70. Boehringer Ingelheim Company Information Table 71. Boehringer Ingelheim Business Overview Table 72. Boehringer Ingelheim Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 73. Boehringer Ingelheim Scopolamine Product Portfolio Table 74. Boehringer Ingelheim Recent Development Table 75. Fine Chemicals Corporation Company Information Table 76. Fine Chemicals Corporation Business Overview Table 77. Fine Chemicals Corporation Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 78. Fine Chemicals Corporation Scopolamine Product Portfolio Table 79. Fine Chemicals Corporation Recent Development Table 80. Phytex Australia Company Information Table 81. Phytex Australia Business Overview Table 82. Phytex Australia Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 83. Phytex Australia Scopolamine Product Portfolio Table 84. Phytex Australia Recent Development Table 85. Alchem International Company Information Table 86. Alchem International Business Overview Table 87. Alchem International Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 88. Alchem International Scopolamine Product Portfolio Table 89. Alchem International Recent Development Table 90. Guangzhou Hanfang Company Information Table 91. Guangzhou Hanfang Business Overview Table 92. Guangzhou Hanfang Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 93. Guangzhou Hanfang Scopolamine Product Portfolio Table 94. Guangzhou Hanfang Recent Development Table 95. Alkaloids Corporation Company Information Table 96. Alkaloids Corporation Business Overview Table 97. Alkaloids Corporation Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 98. Alkaloids Corporation Scopolamine Product Portfolio Table 99. Alkaloids Corporation Recent Development Table 100. Luyin Company Information Table 101. Luyin Business Overview Table 102. Luyin Scopolamine Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 103. Luyin Scopolamine Product Portfolio Table 104. Luyin Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Scopolamine Distributors List Table 108. Scopolamine Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Scopolamine Product Image Figure 2. Global Scopolamine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Scopolamine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Scopolamine Sales (2021-2032) & (Kg) Figure 5. Global Scopolamine Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Scopolamine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Scopolamine Butylbromide Image Figure 10. Scopolamine Hydrobromide Image Figure 11. Others Image Figure 12. Global Scopolamine Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global Scopolamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Scopolamine Sales Volume Share by Type (2021-2032) Figure 15. Global Scopolamine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Scopolamine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Scopolamine Sales Value Share by Type (2021-2032) Figure 18. Tablets Image Figure 19. Injection Image Figure 20. Patches Image Figure 21. Global Scopolamine Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 22. Global Scopolamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Scopolamine Sales Volume Share by Application (2021-2032) Figure 24. Global Scopolamine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Scopolamine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Scopolamine Sales Value Share by Application (2021-2032) Figure 27. Global Scopolamine Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global Scopolamine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Scopolamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Scopolamine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Scopolamine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Scopolamine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Scopolamine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Scopolamine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Scopolamine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Scopolamine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Scopolamine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Scopolamine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Scopolamine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Scopolamine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Scopolamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Scopolamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Scopolamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Scopolamine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Scopolamine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Scopolamine Butylbromide
  • Scopolamine Hydrobromide
  • Others
Applications
  • Tablets
  • Injection
  • Patches
Companies covered
  • Alkaloids of Australia
  • Boehringer Ingelheim
  • Fine Chemicals Corporation
  • Phytex Australia
  • Alchem International
  • Guangzhou Hanfang
  • Alkaloids Corporation
  • Luyin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Scopolamine Sales Value (2021-2032)
  4. 1.2.2 Global Scopolamine Sales Volume (2021-2032)
  5. 1.2.3 Global Scopolamine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Scopolamine Market Dynamics
  1. 2.1 Scopolamine Industry Trends
  2. 2.2 Scopolamine Industry Drivers
  3. 2.3 Scopolamine Industry Opportunities and Challenges
  4. 2.4 Scopolamine Industry Restraints
3 Scopolamine Market by Company
  1. 3.1 Global Scopolamine Company Revenue Ranking in 2025
  2. 3.2 Global Scopolamine Revenue by Company (2021-2026)
  3. 3.3 Global Scopolamine Sales Volume by Company (2021-2026)
  4. 3.4 Global Scopolamine Average Price by Company (2021-2026)
  5. 3.5 Global Scopolamine Company Ranking (2024-2026)
  6. 3.6 Global Scopolamine Company Manufacturing Base and Headquarters
  7. 3.7 Global Scopolamine Company Product Type and Application
  8. 3.8 Global Scopolamine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Scopolamine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Scopolamine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Scopolamine Market by Type
  1. 4.1 Scopolamine Type Introduction
  2. 4.1.1 Scopolamine Butylbromide
  3. 4.1.2 Scopolamine Hydrobromide
  4. 4.1.3 Others
  5. 4.2 Global Scopolamine Sales Volume by Type
  6. 4.2.1 Global Scopolamine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Scopolamine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Scopolamine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Scopolamine Sales Value by Type
  10. 4.3.1 Global Scopolamine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Scopolamine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Scopolamine Sales Value Share by Type (2021-2032)
5 Scopolamine Market by Application
  1. 5.1 Scopolamine Application Introduction
  2. 5.1.1 Tablets
  3. 5.1.2 Injection
  4. 5.1.3 Patches
  5. 5.2 Global Scopolamine Sales Volume by Application
  6. 5.2.1 Global Scopolamine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Scopolamine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Scopolamine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Scopolamine Sales Value by Application
  10. 5.3.1 Global Scopolamine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Scopolamine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Scopolamine Sales Value Share by Application (2021-2032)
6 Scopolamine Regional Sales and Value Analysis
  1. 6.1 Global Scopolamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Scopolamine Sales by Region (2021-2032)
  3. 6.2.1 Global Scopolamine Sales by Region: 2021-2026
  4. 6.2.2 Global Scopolamine Sales by Region (2027-2032)
  5. 6.3 Global Scopolamine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Scopolamine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Scopolamine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Scopolamine Sales Value by Region (2027-2032)
  9. 6.5 Global Scopolamine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Scopolamine Sales Value (2021-2032)
  12. 6.6.2 North America Scopolamine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Scopolamine Sales Value (2021-2032)
  15. 6.7.2 Europe Scopolamine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Scopolamine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Scopolamine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Scopolamine Sales Value (2021-2032)
  21. 6.9.2 South America Scopolamine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Scopolamine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Scopolamine Sales Value Share by Country, 2025 VS 2032
7 Scopolamine Country-level Sales and Value Analysis
  1. 7.1 Global Scopolamine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Scopolamine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Scopolamine Sales by Country (2021-2032)
  4. 7.3.1 Global Scopolamine Sales by Country (2021-2026)
  5. 7.3.2 Global Scopolamine Sales by Country (2027-2032)
  6. 7.4 Global Scopolamine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Scopolamine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Scopolamine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Scopolamine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Scopolamine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Scopolamine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Scopolamine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Scopolamine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Scopolamine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Scopolamine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Scopolamine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Scopolamine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Scopolamine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Scopolamine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Scopolamine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Scopolamine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Scopolamine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Scopolamine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Scopolamine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Scopolamine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Scopolamine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Scopolamine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Scopolamine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Scopolamine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Scopolamine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Scopolamine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Scopolamine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Scopolamine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Scopolamine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Scopolamine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Scopolamine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Scopolamine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Scopolamine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Scopolamine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Scopolamine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Scopolamine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Scopolamine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Scopolamine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Scopolamine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Scopolamine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Scopolamine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Scopolamine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Scopolamine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Scopolamine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Scopolamine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Scopolamine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Scopolamine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Scopolamine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Scopolamine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Scopolamine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Scopolamine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Scopolamine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Scopolamine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Scopolamine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Scopolamine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Scopolamine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Scopolamine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Scopolamine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Scopolamine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Scopolamine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Scopolamine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Scopolamine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Scopolamine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Scopolamine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Scopolamine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Scopolamine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Scopolamine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Scopolamine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Scopolamine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Scopolamine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Scopolamine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Scopolamine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Scopolamine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Scopolamine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Scopolamine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Scopolamine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Scopolamine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Scopolamine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Scopolamine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Scopolamine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Scopolamine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Scopolamine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Scopolamine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Scopolamine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Scopolamine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Scopolamine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Scopolamine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alkaloids of Australia
  2. 8.1.1 Alkaloids of Australia Company Information
  3. 8.1.2 Alkaloids of Australia Business Overview
  4. 8.1.3 Alkaloids of Australia Scopolamine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alkaloids of Australia Scopolamine Product Portfolio
  6. 8.1.5 Alkaloids of Australia Recent Developments
  7. 8.2 Boehringer Ingelheim
  8. 8.2.1 Boehringer Ingelheim Company Information
  9. 8.2.2 Boehringer Ingelheim Business Overview
  10. 8.2.3 Boehringer Ingelheim Scopolamine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Boehringer Ingelheim Scopolamine Product Portfolio
  12. 8.2.5 Boehringer Ingelheim Recent Developments
  13. 8.3 Fine Chemicals Corporation
  14. 8.3.1 Fine Chemicals Corporation Company Information
  15. 8.3.2 Fine Chemicals Corporation Business Overview
  16. 8.3.3 Fine Chemicals Corporation Scopolamine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fine Chemicals Corporation Scopolamine Product Portfolio
  18. 8.3.5 Fine Chemicals Corporation Recent Developments
  19. 8.4 Phytex Australia
  20. 8.4.1 Phytex Australia Company Information
  21. 8.4.2 Phytex Australia Business Overview
  22. 8.4.3 Phytex Australia Scopolamine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Phytex Australia Scopolamine Product Portfolio
  24. 8.4.5 Phytex Australia Recent Developments
  25. 8.5 Alchem International
  26. 8.5.1 Alchem International Company Information
  27. 8.5.2 Alchem International Business Overview
  28. 8.5.3 Alchem International Scopolamine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Alchem International Scopolamine Product Portfolio
  30. 8.5.5 Alchem International Recent Developments
  31. 8.6 Guangzhou Hanfang
  32. 8.6.1 Guangzhou Hanfang Company Information
  33. 8.6.2 Guangzhou Hanfang Business Overview
  34. 8.6.3 Guangzhou Hanfang Scopolamine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangzhou Hanfang Scopolamine Product Portfolio
  36. 8.6.5 Guangzhou Hanfang Recent Developments
  37. 8.7 Alkaloids Corporation
  38. 8.7.1 Alkaloids Corporation Company Information
  39. 8.7.2 Alkaloids Corporation Business Overview
  40. 8.7.3 Alkaloids Corporation Scopolamine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Alkaloids Corporation Scopolamine Product Portfolio
  42. 8.7.5 Alkaloids Corporation Recent Developments
  43. 8.8 Luyin
  44. 8.8.1 Luyin Company Information
  45. 8.8.2 Luyin Business Overview
  46. 8.8.3 Luyin Scopolamine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Luyin Scopolamine Product Portfolio
  48. 8.8.5 Luyin Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Scopolamine Value Chain Analysis
  2. 9.1.1 Scopolamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Scopolamine Sales Mode & Process
  6. 9.2 Scopolamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Scopolamine Distributors
  9. 9.2.3 Scopolamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst